Metastatic Thyroid Cancer Therapy Optimization With 124I PET Dosimetry

Clinical trial NCT05299437 · UNKNOWN

Trial details

NCT number: NCT05299437
Sponsor: Carlo Chiesa
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Differentiated Thyroid Cancer

Start date: 2021-05-12
Primary completion: 2024-03-30
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.